Professional Documents
Culture Documents
CUCMS TEAM 1
OVERVIEW
Relieved by rest
INTERMITTENT
CLAUDICATION
[1]
Causes :
Atherosclerotic
Non-atherosclerotic (thromboangitis obliterans)
Non-arterial causes
Anatomical Review :
Tunica Intima
Tunica Media
Tunica Adventitia
[4]
Aorta
Vena cava
[5]
PERIPHERAL ARTERY
DISEASE
[6]
PAD
ATHEROSCLEROSIS
THROMBOANGITIS
OBLITERANS
ATHEROSCLEROSIS
Atherosclerosis is the most common pathology
associated with PAD.
Non-modifiable
Genetic predisposition
Modifiable
Hyperlipidemia
Hypertension
Cigarette smoking
Diabetes mellitus
MECHANISM
Hyperglycemia
Smoking
Hypertension
Endothelial
dysfunction
and injury
Smooth muscle
cell proliferation
Atheroma
[9]
Hyperlipidemia
Lipoprotein
accumulation
Inflammatory
reaction
Macrophage action
(foam cells)
Lipid
accumulation
(Fatty streak)
HISTOPATHOLOGY OF
ATHEROSCLEROSIS
Normal artery
(no occlusion)
[10]
Location of lesion
For bilateral
intermittent
claudication to
occur, the lesion
should be located
at the abdominal
aorta or the
branching point of
the common
iliac arteries.
THROMBOANGITIS
OBLITERANS (TAO)
[11]
Location of lesion
In TAO, the
lesion usually
located at
infrapopliteal
medium-sized
and small
arteries
[13]
[14]
PAD
ATHEROSCLEROSIS
THROMBOANGITIS OBLITERANS
Definition
Location
Risk Factors
Non-modifiable
Age
Gender
Genetic predisposition
Modifiable
Hyperlipidemia
Hypertension
Cigarette smoking
Diabetes mellitus
Symptoms
Coronary heart
disease
involvement
Yes
No
DIAGNOSIS METHODS
[17]
CONCLUSION
Complaint: severe pain over both the legs midway
while walking uphill to a temple.
Diagnosis: Peripheral artery disease (PAD)
[atherosclerosis & thromboangiitis obliterans].
Further investigation has to be carried out to
confirm the diagnosis.
PRINCIPLE MANAGEMENT
[18]
Invasive Therapy
Limb
revascularization
Fogarty catheter
thrombectomy
Peripheral
Percutaneous
Transluminal
Angioplasty
Non-invasive Therapy
Non pharmacological
treatment
Lifestyle modification
Smoking cessation
Physical activity
Balanced diet
Management of risk factors
Anti hypertensive
Oral hypoglycemic agent
REFERENCES
[1], [14], [15], [17] Macleod, John. Clinical Examination. 13th ed. London: Elsevier Ltd,
2013
[2] Moore, Keith L., Dalley, Arthur F. II. Clinically Oriented Anatomy. 7th ed. Baltimore:
Lippincott Williams & Wilkins, 2014
[3], [4], Mescher, Anthony L. Junquieras Basic Histology Text and Atlas. 13th ed. New
York: McGraw Hill, 2013
[5], [6], [18] Creager, Mark A., Libby, Peter. Braunwalds Heart Disease: A Textbook of
Cardiovascular Medicine. 10th ed. New York: Elsevier Ltd, 2015.
[7], [8], [9], [10] Kumar, Vinay., Abbas, Abul K.., Aster, John C.. Robbins Basic Pathology.
9th ed. Philadelphia: Elsevier Saunders, 2013
[11], [12] Cronenwett, Jack L., Johnston, K. Wayne. Rutherfords Vascular Surgery. 8th ed.
Philadelphia: Elsevier Saunders, 2014